Search CommunityWalk:


Sucampo Pharmaceuticals, Inc.

4520 EastWest Highway
3rd Floor
Bethesda, MD, USA

Category: Pharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of medicines based on prostones. The company was founded by Ryuji Ueno and Sachiko Kuno in 1996. It has two wholly owned subsidiaries that include: Sucampo Pharma Europe, Ltd and Sucampo Pharma, Ltd.

Sucampo leverages its prostone technology to develop and commercialize novel pharmaceutical products to treat unmet medical needs, particularly those diseases affecting an aging population. The company uses proprietary technologies to develop treatments for a variety of gastrointestinal, respiratory, vascular and central nervous system diseases and disorders. Its products are based on prostones which are a class of compounds derived from functional fatty acids that occur naturally in the human body.

Sucampo's product portfolio includes: AMITIZA® indicated for the treatment of chronic idiopathic constipation, irritable bowel syndrome and opioid induced bowel dysfunction; Rescula indicated for the treatment of glaucoma and dry age-related macular degeneration (dry AMD); Cobiprostone indicated for the treatment of chronic obstructive pulmonary disease (COPD), oral mucositis, and prevention of non-steroidal anti-inflammatory drug (NSAID) induced ulcers; SPI-3608 indicated for the treatment of spinal stenosis; etc.

Sucampo has collaborations with R-Tech Ueno, Ltd., ABBOTT Japan Co., Ltd., Takeda Pharmaceutical Company Limited, PHT Corporation, Medidata Solutions etc.